Tapahtumakalenteri
Dissertation: Jukka Vanhanen
Jukka Vanhanen, University of Helsinki, Faculty of Medicine
Transcranial magnetic stimulation and neuromodulation in disorders of the sensorimotor system
Opponent: Professor Jean-Pascal Lefaucheur, Université Paris-Est Créteil,Créteil, France
Aloitusaika: 13.09.2024 12:00
Lopetusaika: 13.09.2024 14:00
Kesto: 2 hours
Dissertation: Wafa Wahbi
Wafa Wahbi, University of Helsinki, Faculty of Medicine
Advancing Preclinical Evaluation : 3D and Zebrafish Models for Head and Neck Cancer Treatment Testing
Opponent: PhD Kirsi Ketola, University of Eastern Finland
Aloitusaika: 13.09.2024 13:00
Lopetusaika: 13.09.2024 15:00
Kesto: 2 hours
Dissertation: Marika Smeds
Marika Smeds, University of Helsinki, Faculty of Medicine
Spontaneous intracerebral hemorrhage : oxygen treatment, prognosis and economical burden of patients requiring intensive care
Opponent: professor Andrew Udy, Monash University
Aloitusaika: 13.09.2024 13:00
Lopetusaika: 13.09.2024 15:00
Kesto: 2 hours
Studia Medicina: Suolistosyöpä yleistyy mutta ennuste paranee
Suolistosyöpä yleistyy mutta ennuste paraneeprofessori Perttu Arkkila HY/HUS Suolistosyövän seulonnan avulla varhaisempaan diagnoosiin
Osastonylilääkäri, dosentti Anna Lepistö HY/HUS Suolistosyövän hoito tänään
professori emerita Helena Isoniemi HY/HUS: Etäpesäke maksassa – onko potilaalla toivoa?
Puheenjohtajana toimii erikoislääkäri, dosentti Johanna Louhimo HY/HUS
Aloitusaika: 18.09.2024 17:00
Lopetusaika: 18.09.2024 19:00
Kesto: 1 hour
iCAN science seminar: Dr. Daniel Hodson
Deciphering the Genomics of Aggressive Lymphomas
S
peaker: Dr. Daniel
Hodson, MD, PhD
Host:
Prof. Sirpa Leppä
Minibio:
Dr Hodson studied medicine at Cambridge and Oxford Universities before training
in clinical haematology in Cambridge. He undertook a University of Cambridge
PhD in molecular immunology supervised by Dr Martin Turner at the Babraham
Institute. In 2010 he moved as a Kay Kendall Leukaemia Fund (KKLF)
Post-doctoral Fellow to the lab of Dr Louis Staudt at the National Cancer
Institute, NIH, USA to study the functional genomics of aggressive B cell
lymphoma. In 2015 he was awarded a Medical Research Council (MRC)
Clinician Scientist Fellowship and returned to Cambridge to establish a
research group in the Welcome MRC Cambridge Stem Cell Institute, University of
Cambridge. In 2021 he was awarded a Cancer Research UK Senior Research
Fellowship and in 2023 a European Research Council Consolidator award.
The
Hodson Group researches the molecular mechanisms that underlie lymphomagenesis
with a view to identifying new targets for designer anti-lymphoma therapies.
Key themes in his lab are molecular profiling (especially ctDNA) to
resolve genetic heterogeneity of DLBCL, novel approaches to model the
functional genetics of lymphoma, and the mechanistic contribution of RNA
helicases in lymphomagenesis. Dr Hodson is also a practising clinician and an
honorary Haematology consultant. He runs an active portfolio of clinical
trials to study the effect of novel therapies in patients with lymphoma and
chairs the UK NCRI Lymphoma Translational Science Subgroup.
Aloitusaika: 20.09.2024 09:00
Lopetusaika: 20.09.2024 10:00
Kesto: